David Brailer reports a stock award at TEVA
By AlphaYouPublished Form 4
BRAILER DAVID J
Reporting filer
David Brailer reports a stock award, not an open-market purchase or sale, in Teva Pharmaceutical Industries Ltd. Form 4 filed Nov 12, 2026 lists 1 entry.
- Disclosed
- Nov 12, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Restricted Share Units (derivative) | BRAILER DAVID J | 2026-11-10 | A | Grant or award | 3326 | 0 | 3,326 | 2 days | Filed terms
|
Restricted Share Units (derivative)
- Owner
- BRAILER DAVID J
- Date
- 2026-11-10
- Code
- A
- Action
- Grant or award
- Quantity
- 3326
- Price
- 0
- Following holdings
- 3,326
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Restricted Share Units
- id: F1
- transaction Date: 2026-11-10
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 3326
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F2
- id: F2
- underlying Security Title: Ordinary Shares
- underlying Security Shares: 3326
- shares Owned Following Transaction: 3326
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- BRAILER DAVID J: Director.
- F1: Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- F2: Restricted share units were granted on November 10, 2026 and vest on November 10, 2027.
Original sources
Prepared automatically from public filing data. Report a correction.